14. Treatment of Acutely Decompensated Heart Failure

  1. Barry H. Greenberg1,
  2. Denise D. Barnard1,
  3. Sanjiv M. Narayan2 and
  4. John R. Teerlink3,4
  1. John R. Teerlink MD, FACC, FAHA, FESC3,4

Published Online: 14 SEP 2010

DOI: 10.1002/9780470669402.ch14

Management of Heart Failure

Management of Heart Failure

How to Cite

Teerlink, J. R. (2010) Treatment of Acutely Decompensated Heart Failure, in Management of Heart Failure (eds B. H. Greenberg, D. D. Barnard, S. M. Narayan and J. R. Teerlink), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470669402.ch14

Editor Information

  1. 1

    Division of Cardiology, University of California, San Diego, California, USA

  2. 2

    University of California and Veterans Affairs Medical Center, San Diego, California, USA

  3. 3

    Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA

  4. 4

    School of Medicine, University of California, San Francisco, California, USA

Author Information

  1. 3

    Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA

  2. 4

    School of Medicine, University of California, San Francisco, California, USA

Publication History

  1. Published Online: 14 SEP 2010
  2. Published Print: 8 OCT 2010

ISBN Information

Print ISBN: 9780470753798

Online ISBN: 9780470669402

SEARCH

Keywords:

  • treatment of acutely decompensated heart failure;
  • acute heart failure (AHF), relatively ignored - compared to chronic or congestive heart failure (CHF);
  • acute heart failure, based on specific clinical characteristics - presented by European Society of Cardiology heart failure guidelines;
  • AHF, and pathophysiological abnormality - with identifiable trigger or precipitating event;
  • Acute Decompensated Heart Failure National Registry (ADHERE) - industry-sponsored, large, national (USA);
  • acute heart failure pathophysiology;
  • dyspnea, most common symptom - in patients with AHF;
  • pulmonary artery catheter (PAC) - important diagnostic tool in selected patients;
  • phosphodiesterase inhibitors (PDEI) - and cAMP, a ubiquitous signaling molecule increasing inotropy;
  • pre-discharge phase - focusing on goals of optimizing chronic oral therapy

Summary

This chapter contains sections titled:

  • Introduction

  • Definition and classification of acute heart failure

  • Epidemiology of acute heart failure (AHF)

  • Pathophysiology of acute heart failure

  • Symptoms in acute heart failure

  • Diagnosis of acute heart failure

  • Treatment for acute heart failure

  • Future treatment of acute heart failure

  • References